Jessie Lu: AAPS 2011 Profile and Podcast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Jessie Lu: AAPS 2011 Profile and Podcast


Jessie Lu



Jessie Lu

Add this Podcast feed to your media player



Wenjie Jessie Lu received her college education from Peking University in China, where she studied Biological Sciences. She is now a senior PhD student at Indiana University School of Medicine working with Dr David Flockhart in the Division of Clinical Pharmacology. She is interested in personalized medicine, with a research focus on breast cancer therapeutics, and her work has generated a number of first-author papers in peer reviewed journals.

View Full Research Presentation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here